ArticleFrontiers in neurology2026
Development and validation of multiple machine learning models for identifying factors associated with walking ability in ischemic stroke patients: a single-center retrospective study with SHAP approach.
Article in Frontiers in neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: The aim of this study was to develop and validate machine learning (ML) models that integrate inflammatory biomarkers with clinical indicators to identify factors associated with walking ability in patients with ischemic stroke (IS). The major research question was which ML model achieves optimal discriminative performance for gait impairment in IS patients, and which factors are the key factors of walking ability in this population. Methods: This retrospective cohort study enrolled 1,650 patients diagnosed with ischemic stroke. The participants were randomly allocated to a training set (70%) and a validation set (30%). Data on clinical, laboratory, and imaging variables were collected. Feature selection was performed using the Least Absolute Shrinkage and Selection Operator (LASSO) regression, the Boruta algorithm, and logistic regression. Six machine learning models were developed. SHapley Additive exPlanations (SHAP) analysis was applied to the best-performing model. Results: Five significant factors were screened: the neutrophil-to-lymphocyte ratio (NLR), age, gender, occipital lobe and frontal lobe lesions. Random forest (RF) achieved optimal performance with an AUC of 0.868 in the training set and 0.681 in the test set. SHAP analysis prioritized NLR as the top contributor. Conclusions: The ML models show preliminary promise as screening tools for early risk stratification for gait impairment in IS patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.